CDX2 and Hyperglycemia: After CDX2 overexpression and knockdown of CFTR under HG conditions, CDX2 cannot present the suppression of Wnt/β-catenin signaling to inhibit hyperglycemia-associated renal tubular lesions (Figure 6).